Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Persistent Pain to Impair Daily Activities Following Thoracic Surgery

This study has been completed.
Information provided by (Responsible Party):
Kim Wildgaard, Rigshospitalet, Denmark Identifier:
First received: January 4, 2012
Last updated: January 5, 2012
Last verified: January 2012
Can pain impairment of daily activities be shown to be procedure specific, and thus used as an alternative to pain scoring.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Persistent Pain to Impair Daily Activities Following Thoracic Surgery

Further study details as provided by Rigshospitalet, Denmark:

Primary Outcome Measures:
  • Pain impairment [ Time Frame: >12 months ] [ Designated as safety issue: No ]
    We measure persistent pain impairment in patient > 12 months folowing surgery

Enrollment: 396
Study Start Date: August 2010
Study Completion Date: December 2010
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Thoracic surgery
Lung cancer patients


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients having thoracic surgery for lung cancer

Inclusion Criteria:

  • Age < 18 years old
  • Elective lung cancer surgery (VATS)

Exclusion Criteria:

  • Non-Danish residence
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01505322

Section for Surgical Pathophysiology 4074
Copenhagen,, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Principal Investigator: Kim Wildgaard, MD Section for Surgical Pathophysiology
Study Director: Henrik Kehlet, MD Section for Surgical Pathophysiology
  More Information

Responsible Party: Kim Wildgaard, MD, Rigshospitalet, Denmark Identifier: NCT01505322     History of Changes
Other Study ID Numbers: RH2011-srv01 
Study First Received: January 4, 2012
Last Updated: January 5, 2012
Health Authority: Denmark: Danish Board of Health

Keywords provided by Rigshospitalet, Denmark:
daily activities processed this record on October 21, 2016